MedPath

Bazell Pharma AG

🇨🇭Switzerland
Ownership
Subsidiary
Established
2009-01-01
Employees
-
Market Cap
-
Website

Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)

Phase 2
Withdrawn
Conditions
Eosinophilic Esophagitis
Interventions
First Posted Date
2022-01-28
Last Posted Date
2024-08-23
Lead Sponsor
Bazell Pharma AG
Registration Number
NCT05214599
© Copyright 2025. All Rights Reserved by MedPath